Advertisement
Advertisement
Avecho Biotechnology Limited (AVE.AX)
ASX - ASX Delayed Price. Currency in AUD
Follow
At close: 03:52PM AEDT
Advertisement
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 0.0040 |
| Open | 0.0040 |
| Bid | 0.0040 x 261087700 |
| Ask | 0.0050 x 105818800 |
| Day's Range | 0.0040 - 0.0040 |
| 52 Week Range | 0.0040 - 0.0160 |
| Volume | |
| Avg. Volume | 2,585,951 |
| Market Cap | 12.142M |
| Beta (5Y Monthly) | 1.69 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0000 |
| Earnings Date | Aug 31, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | May 19, 1997 |
| 1y Target Est | N/A |
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Subscribe to Yahoo Finance Plus to view Fair Value for AVE.AX
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
News DirectAvecho Biotechnology CEO optimistic about phase III insomnia CBD trial
Avecho Biotechnology Limited (ASX:AVE) CEO Dr Paul Gavin speaks with Proactive after announcing that the company is looking to raise approximately $11 million. Proceeds from the raise will be used ...
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
© 2023 Yahoo. All rights reserved.
